Year: 2023
Peter BordesCollective Audience Appoints Technology Visionary, Investor, and Executive Leader, Peter Bordes, as Chief Executive OfficerNEW YORK, Dec. 11, 2023 (GLOBE NEWSWIRE) — Collective Audience, Inc. (Nasdaq: CAUD), a leading innovator of audience based performance advertising and media solutions, has appointed Peter Bordes as chief executive officer, succeeding Brent Suen who will continue to serve on the board of directors.A lifelong entrepreneur, operator and venture investor, Bordes brings to the company more than 30 years of executive and board experience leading private and public companies across the AdTech, media, AI, fintech and technology sectors. His career and investing have focused on innovation and disruptive technologies that drive digital transformation.
“I have followed Peter’s career since the early...
Alto Ingredients, Inc. Publishes Sustainability Summary
Written by Customer Service on . Posted in Public Companies.
PEKIN, Ill., Dec. 11, 2023 (GLOBE NEWSWIRE) — Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer and distributor of specialty alcohols and essential ingredients, has published its inaugural Sustainability Summary outlining the company’s performance in key areas, such as environmental, health and safety, along with the strategy and vision for advancements in sustainability, responsible sourcing, and risk management.
“As a renewables company, we are dedicated to implementing sustainable best practices that are good for our business, our stakeholders and our planet,” said Bryon McGregor, President and CEO of Alto Ingredients. “From integrating innovative practices at our facilities that ensure optimal efficiency, contributing to a lower carbon footprint with our ethanol fuel, and to giving back to the community through...
KH Group’s has made follow-on investment in Indoor
Written by Customer Service on . Posted in Public Companies.
KH Group PlcPress Release 11 December 2023 at 3:30 pm EET
KH Group’s has made follow-on investment in Indoor
KH Group together with other shareholders of Indoor Group Holding Oy (“Indoor”) have made combined EUR 2.8 million follow-on investments in Indoor. These follow-on investments were made by subordinated loan. Loan proceeds are used to repay interest-bearing debts. The follow-on investments strengthen Indoor’s balance sheet accordingly.
KH Group Plc’s share of the subordinated loan in Indoor is EUR 2.1 million. This arrangement has been finalised today and will not affect the ownership structure in Indoor Group Holding Oy.
KH GROUP PLC
FURTHER INFORMATION: CEO Lauri Veijalainen, puh. +358 46 876 1648
DISTRIBUTION: Major mediawww.khgroup.com
Sievi Capital is now a conglomerate with a new name KH Group. Our four business areas are...
Allison Abraham Retires as Co-Chair and Member of the Beyond, Inc. Board of Directors
Written by Customer Service on . Posted in Public Companies.
Marcus Lemonis will serve as the Chairman of the Board
MIDVALE, Utah, Dec. 11, 2023 (GLOBE NEWSWIRE) — Beyond, Inc., (NYSE: BYON) (“Beyond” or the “Company”), the parent company of online furniture and home furnishings retailer Bed Bath & Beyond, formerly known as Overstock, today announced that, on December 10, 2023, Allison H. Abraham notified the Board of Directors of Beyond (“the Board”) of her decision to retire. As part of that transition, Ms. Abraham resigned as a Director of the Company, effective immediately. Marcus Lemonis will transition to the role of Chairman of the Company’s Board of Directors.
Ms. Abraham said, “I thank the Board, management, and rest of the Beyond family for their support over the years. It has been an honor to work for the Company and represent our shareholders for more than two decades....
FDA Accepts for Review Resubmitted NDA for TransCon PTH (Palopegteriparatide) in Adult Patients with Hypoparathyroidism
Written by Customer Service on . Posted in Public Companies.
– PDUFA goal date is May 14, 2024
COPENHAGEN, Denmark, Dec. 11, 2023 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today announced that the U.S. Food & Drug Administration (FDA) has accepted for review the Company’s resubmitted New Drug Application (NDA) for TransCon PTH (palopegteriparatide) for the treatment of adult patients with hypoparathyroidism. The agency considered the resubmission a complete, class 2 response and set a Prescription Drug User Fee Act (PDUFA) goal date of May 14, 2024. In the United States, TransCon PTH (palopegteriparatide) is an investigational prodrug of parathyroid hormone (PTH [1-34]) for adult patients with hypoparathyroidism.
“We are pleased that the FDA can continue its review of TransCon PTH and look forward to working with the agency during its review,” said Jan Mikkelsen, President...
Coherus Announces Updated NCCN Clinical Practice Guidelines Positioning LOQTORZI™ (toripalimab-tpzi) as Preferred Category 1 Regimen for First-Line Treatment of Cancer of the Nasopharynx
Written by Customer Service on . Posted in Public Companies.
– NCCN Guidelines recommend LOQTORZI as the only Preferred Category 1 treatment option in first-line treatment for adults with metastatic or recurrent locally advanced NPC in combination with chemotherapy; LOQTORZI monotherapy also recommended as the only preferred regimen in subsequent lines of therapy –
-– LOQTORZI is the first and only FDA-approved treatment for recurrent or metastatic NPC in all lines of therapy–
REDWOOD CITY, Calif., Dec. 11, 2023 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (Coherus, Nasdaq: CHRS) announced today that the National Comprehensive Cancer Network (NCCN) has updated the clinical practice guidelines for nasopharyngeal carcinoma (NPC) to include LOQTORZI™ (toripalimab-tpzi) as a preferred, category 1 first-line treatment option for adults with metastatic or recurrent locally advanced NPC...
RespireRx Pharmaceuticals Inc. Announces Agreement with Ponto Ventures to Drive Business Development with Will Clodfelter as RespireRx Part-Time Senior VP of Business Development
Written by Customer Service on . Posted in Public Companies.
Glen Rock, N.J., Dec. 11, 2023 (GLOBE NEWSWIRE) — RespireRx Pharmaceuticals Inc. (OTC Pink Market: RSPI) (“RespireRx” or the “Company”), a biopharmaceutical company focused on the discovery and development of innovative and revolutionary treatments to combat diseases caused by disruption of neuronal signaling, is pleased to announce that, on December 6, 2023, it has entered into an agreement with Ponto Ventures LLC providing for Will Clodfelter to serve as RespireRx’s Senior Vice President of Business Development on a part-time basis.
Mr. Clodfelter will initially lead the business development efforts with respect to dronabinol, the lead asset of ResolutionRx Ltd, a wholly-owned Australian subsidiary of the Company. Mr. Clodfelter will collaborate with Jeff Eliot Margolis, the Company’s Senior Vice President, Chief Financial Officer,...
HeartCore Implements New Function to Enhance its Market Leading CMS Platform
Written by Customer Service on . Posted in Public Companies.
NEW YORK and TOKYO, Dec. 11, 2023 (GLOBE NEWSWIRE) — HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or “the Company”), a leading enterprise software and consulting services company based in Tokyo, announced that it has developed and integrated a new “Builder for Creating Admin Screens” functionality into its market leading content management systems (“CMS”) platform, which allows users to create original submission screens within the platform.
HeartCore’s latest “Builder for Creating Admin Screens” function allows users of the CMS platform to effortlessly design and customize their own personalized submission screens tailored specifically to individual needs and preferences. Developing a submission screen in many CMS platforms often requires the involvement and expertise of external production entities or proficient webmasters,...
Arbor Realty Trust Announces an Increase of its Share Repurchase Program to $150 Million
Written by Customer Service on . Posted in Public Companies.
UNIONDALE, N.Y., Dec. 11, 2023 (GLOBE NEWSWIRE) — Arbor Realty Trust, Inc. (NYSE: ABR), today announced that its Board of Directors has approved an increase to the Company’s share repurchase program authorizing the Company to repurchase up to $150 million of its outstanding common stock. The share repurchase program allows shares to be repurchased at management’s discretion from time to time in the open market, through privately negotiated transactions or otherwise in compliance with Rule 10b-18 and Rule 10b5-1 under the Securities Exchange Act of 1934. The share repurchase program also permits the Company to establish Rule 10b5-1 trading plans to repurchase its outstanding shares at times when it might otherwise be prevented from doing so.
This share repurchase program does not obligate the Company to acquire any particular...
BIGG Digital Assets Co-Founder Shone Anstey Returns as a Strategic Advisor; Update on Digital Asset Due Diligence Audit Service Offering
Written by Customer Service on . Posted in Public Companies.
VANCOUVER, British Columbia, Dec. 11, 2023 (GLOBE NEWSWIRE) — BIGG Digital Assets Inc. (“BIGG” or the “Company”) (CSE: BIGG; OTCQX: BBKCF; WKN: A2PS9W), a leading innovator in the digital assets space and owner of Netcoins, and Blockchain Intelligence Group and TerraZero is pleased to announce the addition of Due Diligence Audits to its arsenal of digital asset investigations and compliance services. This strategic move comes in response to the proliferate demand for digital asset auditing solutions arising after the discovery of the multi-billion dollar FTX fraud in November 2022. There is vast business potential, and a regulatory need, within the digital asset market for auditing and due diligence services. BIGG recently completed a proof of reserves and platform due diligence audit for Wonderfi Technologies Inc., Canada’s largest...
